attachment
attachment

Radiology university theory exam writing 30 Marks each questions,full answers writing cover all possible area in given questions

Reading File
I can see the exam questions. Before I proceed, let me clarify which specific questions you need answered, since there are 11 questions (36-46) and each is a 30-mark answer - that's a very large amount of content.
Asking for Preferences

Which questions do you need full 30-mark answers for?

All 11 questions it is. Given the volume and complexity, I'll research and write all answers now using parallel library searches.Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good - I now have enough library material combined with my comprehensive radiology knowledge to write all 11 full answers. Let me compose them now.Here are full 30-mark university exam answers for all 11 questions:

RADIOLOGY UNIVERSITY THEORY EXAM - MODEL ANSWERS


Q.36 PNEUMATOSIS INTESTINALIS (30 Marks)

Definition

Pneumatosis intestinalis (PI) is a condition characterized by the presence of gas within the wall of the gastrointestinal tract (submucosa or subserosa). It is NOT a disease itself but a radiological sign indicating an underlying pathological process. It can affect any segment from esophagus to rectum but most commonly involves the jejunum, ileum, and colon.

Classification

1. Primary (Idiopathic) PI (~15%)
  • No identifiable underlying cause
  • Gas-filled submucosal or subserosal cysts (Pneumatosis cystoides intestinalis)
  • Usually benign, incidental finding
  • Associated with COPD, obstructive lung disease (theory: alveolar rupture - air tracking along perivascular sheaths)
2. Secondary PI (~85%) Subdivided into:
  • Ischemic/Life-threatening (most important to exclude)
  • Non-ischemic/Benign (majority of secondary causes)

Etiopathogenesis - Three Theories

TheoryMechanism
Mechanical theoryMucosal disruption allows intraluminal gas to dissect into bowel wall (trauma, endoscopy, obstruction, peptic ulcer)
Bacterial theoryGas-producing bacteria (H2, CO2) colonize and produce gas within bowel wall (in necrotizing enterocolitis, bowel infarction)
Pulmonary theoryAir from ruptured alveoli tracks down mediastinum and perivascular sheaths into bowel wall (COPD, asthma, barotrauma)

Causes

Life-threatening (ischemic) causes:
  • Mesenteric ischemia / bowel infarction
  • Necrotizing enterocolitis (NEC) in neonates
  • Bowel obstruction with strangulation
  • Sepsis / toxic megacolon
  • Graft-versus-host disease
Benign (non-ischemic) causes:
  • COPD, asthma, barotrauma
  • Steroid therapy, immunosuppression
  • Connective tissue diseases (scleroderma, SLE)
  • Post-endoscopy / colonoscopy
  • Inflammatory bowel disease (Crohn's, ulcerative colitis)
  • Post bone marrow transplant
  • HIV/AIDS
  • Celiac disease

Radiological Features

Plain Abdominal Radiograph (AXR)

  • Mural gas: Linear or curvilinear lucencies running parallel to the bowel wall (submucosal); or rounded/oval lucent foci along serosal surface (subserosal cysts)
  • Portal venous gas: Branching lucencies extending to the liver periphery (peripheral hepatic gas - highly ominous sign of ischemia; distinguishes from biliary gas which is central)
  • Pneumoperitoneum: If perforation has occurred
  • Dilated bowel loops: Indicating obstruction

Ultrasound

  • Echogenic foci within bowel wall with "dirty" acoustic shadowing or ring-down artifact
  • Portal venous gas: Bright echogenic foci moving in portal veins (highly specific)
  • May show peritoneal free fluid

CT Scan (Gold Standard)

CT is the investigation of choice - most sensitive and specific.
CT Findings:
  • Mural gas: Hypodense (gas density, ~-100 to -1000 HU) foci within the bowel wall
    • Bubbly pattern: Multiple small rounded foci in submucosa (more benign)
    • Linear pattern: Continuous linear gas along bowel wall (more ominous for ischemia)
  • Portal venous gas: Branching hypodense foci in portal vein and intrahepatic portal branches extending to within 2 cm of liver capsule
  • Bowel wall thickening / thinning (paper-thin wall = infarction)
  • Lack of bowel wall enhancement after IV contrast = ischemia/necrosis
  • Free peritoneal fluid, ascites
  • Pneumoperitoneum if perforated
  • Mesenteric fat stranding

MRI

  • T1: Gas appears as signal void
  • Less commonly used in acute setting
  • Useful for chronic/follow-up cases

Differentiating Benign from Ominous PI

FeatureBenign PIIschemic PI
Gas patternCyst-like, subserosalLinear, submucosal
Portal venous gasAbsentOften present
Bowel enhancementNormalAbsent (necrosis)
Peritoneal fluidAbsentPresent
ClinicalAsymptomaticPeritonitis, sepsis
Bowel wallNormal thicknessThickened or paper-thin

Portal Venous Gas vs Pneumobilia

FeaturePortal Venous GasPneumobilia
Location in liverPeripheral (within 2 cm of capsule)Central (hilar)
CauseBowel ischemia, sepsisBiliary-enteric fistula, sphincterotomy, surgery
PrognosisOminousUsually benign if in correct context

Management Implications

  • Benign PI: Conservative management, treat underlying cause
  • Ischemic PI: Surgical emergency - exploratory laparotomy, bowel resection
  • The radiologist's role is to identify CT features that distinguish benign from life-threatening PI and communicate urgently

Q.37 MECKEL'S DIVERTICULUM (30 Marks)

Definition

Meckel's diverticulum (MD) is the most common congenital anomaly of the gastrointestinal tract. It is a true diverticulum (contains all layers of bowel wall) arising from the antimesenteric border of the distal ileum, representing a persistent remnant of the vitello-intestinal (omphalomesenteric) duct.

Rule of 2s

  • Occurs in 2% of the population
  • Located within 2 feet (~60 cm) of the ileocecal valve
  • Approximately 2 inches (5 cm) in length
  • 2:1 male to female ratio for symptomatic cases
  • 2 types of ectopic mucosa: gastric (most common) and pancreatic
  • Symptomatic in 2% of those who have it
  • Most commonly presents before age 2 years

Anatomy

  • True diverticulum with all 3 layers (mucosa, muscularis, serosa)
  • Arises from antimesenteric border of ileum
  • Has its own blood supply from a remnant of the vitelline artery (branch of superior mesenteric artery)
  • Contains ectopic mucosa in 50% of symptomatic cases:
    • Gastric mucosa (most common - 85%) - responsible for peptic ulceration and bleeding
    • Pancreatic tissue (second most common)
    • Colonic, duodenal mucosa

Clinical Presentations

  1. Hemorrhage (most common in children) - painless rectal bleeding (bright red to maroon), due to peptic ulceration of adjacent ileal mucosa by ectopic gastric acid
  2. Intestinal obstruction - volvulus, intussusception, Littre's hernia (Meckel's in hernia sac)
  3. Diverticulitis (most common in adults) - mimics acute appendicitis
  4. Perforation - with peritonitis
  5. Umbilical fistula / sinus - if duct remains patent

Radiological Investigations

Plain X-ray

  • Usually normal
  • May show small bowel obstruction (dilated loops, air-fluid levels)
  • Rarely, ectopic calcification (enterolith within MD)

Barium Small Bowel Studies (Enteroclysis/Follow-Through)

  • MD is notoriously difficult to visualize with contrast radiology (Bailey & Love)
  • May appear as a blind-ending sac off the antimesenteric border of distal ileum
  • Barium may fill the lumen
  • Limitations: Cannot detect ectopic mucosa

Ultrasound

  • Limited role; may show tubular structure near terminal ileum
  • May detect complications (inflammatory mass, intussusception)
  • Doppler: blood flow in vitelline artery remnant

Technetium-99m Pertechnetate Scan (Meckel's Scan) - KEY INVESTIGATION

  • Investigation of choice for suspected Meckel's diverticulum with bleeding
  • Principle: 99mTc-pertechnetate is taken up by mucus-secreting cells of gastric mucosa (ectopic gastric tissue in MD)
  • Technique: IV injection of 99mTc-pertechnetate; images at 5-minute intervals for 60 minutes
  • Positive scan: Area of abnormal increased uptake in the right lower abdomen (not present normally) appearing simultaneously with gastric mucosa uptake
  • Sensitivity: ~85% in children, lower in adults
  • Specificity: ~95%
  • Pharmacological enhancement:
    • Pentagastrin: Stimulates uptake (pretreatment)
    • H2-blockers (cimetidine/ranitidine): Block secretion but not uptake (increases target-to-background ratio) - preferred
    • Glucagon: Reduces peristalsis, prevents washout of tracer

CT Scan

  • Cannot specifically diagnose MD unless it demonstrates:
    • Tubular structure arising from antimesenteric border of ileum
    • Inflammation (Meckel's diverticulitis) - inflamed blind-ending structure in RLQ with surrounding fat stranding
    • Complications: abscess, perforation, obstruction
  • CT enterography improves detection
  • Cannot detect ectopic mucosa

MRI / MR Enterography

  • Increasing use in children (no radiation)
  • May show diverticulum and inflammatory changes
  • Cannot detect ectopic mucosa

Angiography

  • For active hemorrhage when nuclear scan is equivocal
  • May show vitelline artery, active bleeding blush

Capsule Endoscopy

  • Good for detecting ectopic mucosa
  • Cannot differentiate MD from other causes of obscure GI bleed

Complications Summary

ComplicationTypical AgeRadiological Finding
HemorrhageChildren99mTc scan positive
ObstructionAll agesSmall bowel obstruction on AXR/CT
DiverticulitisAdultsInflamed mass in RLQ on CT
IntussusceptionChildrenClassic intussusception on US/CT
PerforationAny agePneumoperitoneum

Treatment

  • Symptomatic MD: Surgical diverticulectomy or segmental ileal resection
  • Incidentally found MD: Controversial (resect if young, >2cm, ectopic mucosa suspected, broad neck)

Q.38 ACUTE ABDOMEN IN A 50-YEAR-OLD FEMALE (30 Marks)

Definition

Acute abdomen refers to a clinical syndrome characterized by sudden onset of severe abdominal pain requiring urgent medical or surgical attention, which may be caused by intraperitoneal, retroperitoneal, or extra-abdominal disease.

Special Considerations in a 50-Year-Old Female

At this age, several gynecological, hepatobiliary, and vascular conditions are particularly important to consider alongside the standard causes.

Causes - Classification

A. Gastrointestinal Causes
  1. Acute appendicitis (less common at 50, but still occurs)
  2. Perforated peptic ulcer / gastric ulcer
  3. Acute cholecystitis / biliary colic / choledocholithiasis
  4. Acute pancreatitis
  5. Intestinal obstruction (adhesions, hernia, volvulus, tumor)
  6. Mesenteric ischemia / volvulus
  7. Diverticulitis (sigmoid more common in 50+ age group)
  8. Perforated viscus (from any cause)
  9. Inflammatory bowel disease - Crohn's / UC
  10. Intussusception (in adults, usually pathological lead point - tumor)
B. Gynecological Causes (Important in females)
  1. Ruptured ovarian cyst
  2. Ovarian torsion
  3. Ectopic pregnancy (unlikely at 50 but possible in perimenopause)
  4. Fibroid degeneration / torsion
  5. Tubo-ovarian abscess / pelvic inflammatory disease
  6. Ovarian / uterine malignancy with complication
C. Urological Causes
  1. Renal/ureteric colic (calculus)
  2. Pyelonephritis / perinephric abscess
  3. Acute urinary retention
D. Vascular Causes (Increased at 50)
  1. Ruptured abdominal aortic aneurysm (AAA)
  2. Aortic dissection
  3. Acute mesenteric ischemia (embolic, thrombotic, non-occlusive)
  4. Splenic infarction
E. Hepatic / Splenic
  1. Hepatic abscess
  2. Budd-Chiari syndrome
  3. Splenic abscess / rupture
F. Rare
  1. Adrenal hemorrhage
  2. Rectus sheath hematoma
  3. Referred pain (myocardial infarction, lower lobe pneumonia, pleuritis)

Radiological Approach - Stepwise

Step 1: Plain Abdominal X-ray (AXR) + Erect Chest X-ray

Indications: First-line, rapid, available, cheap
Erect CXR findings:
  • Free air under diaphragm = perforated viscus (needs >0.5 ml air to be visible)
  • Basal pneumonia / empyema (referred pain)
AXR findings:
FindingDiagnosis
Dilated small bowel loops with air-fluid levelsSmall bowel obstruction
Dilated large bowelLarge bowel obstruction / toxic megacolon
No distal gasComplete obstruction
Calcification - RUQGallstones (only 10-15% radio-opaque)
Calcification - LUQ/midRenal/ureteric calculi, pancreatic calcification
Thumbprinting of bowelIschemic colitis
Pneumatosis intestinalisBowel ischemia / NEC
Soft tissue mass in pelvisOvarian mass / fibroid
Abnormal gas shadowsAbscess / fistula

Step 2: Ultrasound (US)

First-line for:
  • Biliary tract disease (cholecystitis, choledocholithiasis)
  • Gynecological causes (cysts, fibroids, torsion, ectopic)
  • Renal tract (hydronephrosis, calculi)
  • AAA screening
  • Appendicitis (limited by gas)
  • Free fluid detection
Findings:
  • Cholecystitis: Thickened gallbladder wall (>3mm), gallstones, pericholecystic fluid, positive Murphy's sign on US
  • Ovarian torsion: Enlarged ovary with absent Doppler flow, peripheral follicles
  • Ectopic: Empty uterus, adnexal mass, free fluid in Pouch of Douglas
  • AAA: Aortic diameter >3 cm, aneurysm or dissection flap
  • Renal calculi: Hydronephrosis, echogenic stone with shadowing
  • Pancreatitis: Edematous pancreas, peripancreatic fluid

Step 3: CT Scan - Investigation of Choice for Acute Abdomen

  • CECT abdomen and pelvis (arterial + portal venous phases) provides definitive diagnosis in most cases
  • Sensitivity and specificity >90% for most causes
CT findings by diagnosis:
ConditionCT Findings
AppendicitisEnlarged appendix >6mm, periappendiceal fat stranding, appendicolith, free fluid
CholecystitisThickened GB wall, pericholecystic fat stranding, GB distension, stones
DiverticulitisColonic diverticula with pericolonic fat stranding, thickened wall, possible abscess or perforation
Perforated peptic ulcerFree air, free fluid, gastric/duodenal wall defect
PancreatitisPancreatic edema, peripancreatic fat stranding, necrosis (CT Severity Index), fluid collections
Small bowel obstructionDilated loops proximal to transition point, collapsed distal bowel
Mesenteric ischemiaBowel wall thickening or thinning, pneumatosis, portal venous gas, SMA/SMV occlusion, whirl sign
Ruptured AAARetroperitoneal hematoma, aortic aneurysm with loss of wall continuity
Ovarian torsionEnlarged ovary, edematous stroma, displaced ipsilateral ovary
Ovarian cyst ruptureCollapsed cyst, free pelvic fluid, adnexal mass

Step 4: Additional Modalities

MRI:
  • In pregnant patients (avoiding radiation)
  • Unclear diagnosis on CT
  • Pelvic masses, fibroids, ectopic
  • Mesenteric ischemia
Fluoroscopy / Contrast Studies:
  • Water-soluble enema for suspected large bowel obstruction or perforation
  • Small bowel follow-through in partial obstruction
Nuclear Medicine:
  • HIDA scan for acute cholecystitis when US equivocal
  • 99mTc WBC scan for occult septic focus
Angiography (Interventional):
  • Active GI bleeding (therapeutic: embolization)
  • Mesenteric ischemia (selective angiography, thrombolysis)
  • Ruptured AAA (EVAR)

Summary Algorithm for 50-Year-Old Female Acute Abdomen

  1. History and clinical exam
  2. AXR + Erect CXR - exclude pneumoperitoneum, obstruction
  3. Ultrasound - biliary, gynecological, renal (fast, no radiation)
  4. CECT abdomen + pelvis - if US inconclusive or surgical emergency suspected
  5. MRI - if pregnant, young, or pelvic pathology needs further evaluation
  6. Interventional procedures as clinically indicated

Q.39 INVESTIGATION OF A 40-YEAR-OLD MALE WITH HAEMOPTYSIS IN A FULLY EQUIPPED RADIO-IMAGING CENTRE (30 Marks)

Definition

Haemoptysis is the coughing up of blood or blood-stained sputum from the respiratory tract (below the glottis). It must be distinguished from haematemesis (vomited blood) and pseudohaemoptysis (nasopharyngeal bleeding).

Causes of Haemoptysis

Common causes:
  1. Pulmonary tuberculosis (TB) - most common in developing countries
  2. Bronchogenic carcinoma (especially in 40-year male smoker)
  3. Bronchiectasis
  4. Acute bronchitis / pneumonia
Less common: 5. Pulmonary embolism with infarction 6. Mitral stenosis / left heart failure 7. Lung abscess 8. Fungal infection (Aspergilloma - "aspergillus ball") 9. Arteriovenous malformation (AVM) 10. Pulmonary vasculitis (Wegener's granulomatosis / GPA) 11. Goodpasture's syndrome 12. Trauma 13. Coagulopathy 14. Cryptogenic (10-20% remain undiagnosed)
In a 40-year male - HIGH PRIORITY to exclude:
  • Bronchogenic carcinoma (squamous cell carcinoma most common)
  • Tuberculosis
  • Bronchiectasis

Radiological Investigations - Sequential Approach

1. Plain Chest Radiograph (CXR) - PA and Lateral

First Investigation - Always Performed
Findings to look for:
FindingDiagnosis
Hilar mass / mediastinal wideningBronchogenic carcinoma
Cavitating lesionTB, lung abscess, carcinoma, aspergilloma
Upper lobe infiltrates, fibrosis, calcificationPost-primary TB
Diffuse bilateral airspace shadowingAlveolar haemorrhage (Goodpasture's, vasculitis)
Peripheral wedge-shaped opacityPulmonary infarction (PE)
Reticulonodular shadowsFibrotic lung disease
Ring shadows / "tram-track" opacitiesBronchiectasis
Rounded opacity with air crescentAspergilloma (mycetoma)
Raised hemidiaphragmSubphrenic process, phrenic nerve palsy (carcinoma)
Pleural effusionCarcinoma, empyema, PE

2. High Resolution CT (HRCT) of Thorax

Most Important Investigation for Haemoptysis
  • Detects lesions invisible on CXR (small tumors, early bronchiectasis)
  • Thin slices (0.5-1.5 mm) through entire thorax
  • Multiplanar reconstruction (MPR), minimum intensity projection (MinIP) for airways
HRCT findings:
  • Bronchiectasis: Signet ring sign (dilated bronchus > accompanying pulmonary artery), tram-track lines on AP view, absence of bronchial tapering, mucous plugging
  • Bronchogenic carcinoma: Spiculated/lobulated mass, hilar/mediastinal adenopathy, pleural effusion, chest wall invasion
  • TB: Upper/posterior lobe consolidation, cavity, satellite nodules, tree-in-bud pattern (endobronchial spread), calcified nodes (Ghon focus, Ranke complex)
  • Aspergilloma: Dense rounded mass within a pre-existing cavity, surrounded by aircrescent (Monod sign/Halo sign), changes with posture (mobile ball)
  • AVM: Feeding artery + draining vein + nidus (pulmonary aneurysm on plain film)
  • Pulmonary infarction: Peripheral wedge-shaped density (Hampton's hump), pleurally-based

3. CT Pulmonary Angiography (CTPA)

  • Investigation of choice for pulmonary embolism
  • Findings: Filling defects in pulmonary arteries, peripheral wedge infarcts, pleural effusion
  • Also evaluates pulmonary arterial anatomy for pre-embolization planning in massive haemoptysis

4. Contrast Enhanced CT (CECT) Thorax

  • Arterial phase for vascular lesions, AVM
  • Mediastinal window for lymph nodes, masses
  • Bronchial artery anatomy (pre-interventional planning)

5. Flexible Bronchoscopy

  • Key procedure (not imaging, but complementary)
  • Localizes bleeding site
  • Samples lesion for histology/microbiology
  • Virtual bronchoscopy from CT data

6. Bronchial Artery Angiography + Embolization (BAE)

For massive/life-threatening haemoptysis
  • Bronchial arteries arise from descending aorta (T5-T6 level)
  • Right bronchial artery often shares origin with right intercostal artery (intercostobronchial trunk - ICBT)
  • Angiographic findings of active bleed: Hypervascularity, tortuous bronchial arteries, arteriovenous shunting, active extravasation of contrast
  • Embolization with polyvinyl alcohol (PVA) particles, coils
  • Success rate 75-90% for stopping acute bleed

7. MRI / MRA

  • Limited role in acute haemoptysis (patient cannot hold breath, motion artifacts)
  • Role: Vascular anomalies, cardiac causes (mitral stenosis - MRI for valvular disease, ventricular function)
  • MR angiography for AVM characterization
  • Useful when iodine contrast is contraindicated

8. Nuclear Medicine (V/Q Scan)

  • Ventilation/Perfusion scan for PE when CTPA is contraindicated (renal failure, contrast allergy)
  • Perfusion defect with normal ventilation = mismatch (positive for PE)

9. PET-CT

  • For staging of confirmed bronchogenic carcinoma
  • Differentiating benign from malignant lesions (FDG avidity)
  • Detecting mediastinal, distant metastases

10. Fluoroscopy

  • Screening for diaphragm movement, hilar masses
  • Barium swallow if esophageal cause suspected

Algorithm for 40-Year Male with Haemoptysis

Step 1: CXR (PA + Lateral) Step 2: HRCT Thorax - if CXR abnormal OR if CXR normal but haemoptysis persists Step 3: CTPA if PE suspected Step 4: Bronchoscopy (guided by CT findings) - tissue diagnosis, localization Step 5: PET-CT if malignancy confirmed for staging Step 6: Bronchial artery angiography + embolization if massive bleed Step 7: MRI/Echocardiography if cardiac cause suspected

Comparison: HRCT vs Bronchoscopy

FeatureHRCTBronchoscopy
Site of diseaseEntire lung parenchyma, airwaysCentral airways only
Small peripheral lesionsDetectsMisses
Tissue diagnosisNo (except CT-guided biopsy)Yes (BAL, biopsy)
Active bleed siteIndirect evidenceDirect visualization
StagingYes (mediastinum, nodes)No

Q.40 ROLE OF MDCT IN ACUTE ABDOMEN (30 Marks)

Introduction

Multi-Detector CT (MDCT) has revolutionized the diagnosis and management of acute abdomen. With its rapid acquisition, multiplanar reconstruction, and the ability to simultaneously evaluate all abdominal and pelvic organs, MDCT has become the cornerstone investigation for acute abdomen in adults.

Technical Advantages of MDCT

FeatureAdvantage
Multiple detector rows (4-320 rows)Faster acquisition, whole abdomen in <5 seconds
Thin slices (0.5-1.25 mm)Isotropic voxels, superior multiplanar reconstruction
Retrospective reconstructionAxial, coronal, sagittal, oblique planes
Wide bore gantryAccommodates critically ill patients
High temporal resolutionMultiphase imaging (arterial, portal venous, delayed)
3D renderingVolume rendering, MIP, MinIP, virtual endoscopy

CT Protocol for Acute Abdomen

Patient preparation: NPO not required in emergency; oral contrast (dilute water-soluble) if available (not mandatory)
Contrast phases:
  1. Non-contrast (Plain) phase: Detects calcification (stones, aortic wall), hemorrhage (hyperattenuating), gas patterns
  2. Arterial phase (25-30 sec): Vascular injuries, active bleeding, bowel ischemia (non-enhancement), hepatic arterial phase, pancreatic parenchyma
  3. Portal venous phase (60-70 sec): Standard phase for abdominal organs - liver, spleen, kidneys, bowel wall enhancement, peritoneal disease
  4. Delayed / Excretory phase (3-5 min): Urinary tract, ureteric calculi, bladder injuries

Role of MDCT in Specific Causes

1. Gastrointestinal Perforation

  • Free air (pneumoperitoneum): Hypodense foci under diaphragm (more sensitive than AXR); as little as 1-2 ml detectable
  • Site of perforation: Bowel wall defect, localized free air adjacent to specific organ
  • Perforated peptic ulcer: Air near lesser sac, extraluminal fluid
  • Perforated colon (diverticulitis, carcinoma): Pericolonic inflammation, pericolic air

2. Intestinal Obstruction

Small bowel obstruction:
  • Transition point: Abrupt change from dilated to collapsed bowel
  • Cause identification: Adhesions (normal bowel at transition), hernia (bowel through defect), volvulus (whirl sign, X-marks-the-spot), tumor (mass at transition)
  • Closed loop obstruction: C or U-shaped dilated segment with two adjacent transitions, high risk of strangulation
  • Strangulation: Mural thickening, pneumatosis, portal venous gas, non-enhancement, mesenteric edema/haziness, ascites
Large bowel obstruction:
  • Carcinoma: Annular "apple-core" lesion
  • Volvulus: Omega loop (sigmoid), coffee bean sign, whirl sign

3. Acute Appendicitis

  • Dilated appendix > 6mm diameter with mural thickening
  • Appendicolith (hyperattenuating)
  • Periappendiceal fat stranding
  • Free fluid in right iliac fossa
  • Phlegmon or abscess formation
  • Perforated: Discontinuity of appendiceal wall, pericecal abscess, free air

4. Acute Cholecystitis

  • Distended gallbladder (> 5 cm width)
  • Mural thickening (>3 mm)
  • Pericholecystic fat stranding
  • Gallstones (hyperattenuating)
  • Subserosal edema (halo sign)
  • Gangrenous cholecystitis: Irregular/absent wall enhancement, intramural gas (emphysematous cholecystitis), mural irregularity
  • Mirizzi syndrome: Stone in Hartmann's pouch compressing common hepatic duct

5. Acute Pancreatitis

  • CT Severity Index (Balthazar Score):
    • Grade A: Normal
    • Grade B: Enlargement alone
    • Grade C: Peripancreatic inflammation
    • Grade D: One fluid collection
    • Grade E: Two+ fluid collections
  • Necrosis: Non-enhancing pancreatic parenchyma (black on CECT) - walled-off necrosis after 4 weeks
  • CT Severity Index = Balthazar grade (0-4) + Necrosis score (0-4) - correlates with morbidity/mortality
  • Complications: Pseudocyst, abscess, hemorrhage, vascular complications (splenic vein thrombosis, pseudoaneurysm)

6. Acute Mesenteric Ischemia

CT Angiography findings:
  • Embolic: Filling defect in SMA (usually proximal, just beyond middle colic artery origin); spares proximal jejunal branches
  • Thrombotic: SMA occlusion at origin; diffuse bowel involvement; atherosclerotic disease in adjacent vessels
  • Non-occlusive (NOMI): Patent vessels, diffuse bowel changes, spasm of SMA branches
  • Bowel wall: Thickening (early) or thinning (late ischemia/infarction), absent enhancement
  • Pneumatosis intestinalis (submucosal/subserosal gas)
  • Portal venous gas: Branching gas in portal veins; ominous sign
  • Bowel dilation, ascites, peritoneal fluid
  • "Whirl sign": Rotation of mesenteric vessels in volvulus
  • Double halo / target sign: Concentric mural thickening in reperfusion edema or intramural hemorrhage

7. Diverticulitis

  • Sigmoid (most common) or right colon
  • Diverticula (outpouchings through bowel wall)
  • Pericolonic fat stranding (hallmark)
  • Mural thickening
  • Complications: Abscess, fistula (colovesical: air in bladder), perforation, obstruction
  • Modified Hinchey classification guides management

8. Abdominal Aortic Aneurysm (AAA) and Rupture

  • Aortic diameter >3 cm = AAA
  • Rupture: Retroperitoneal hematoma (periaortic high-density blood), loss of aortic wall definition
  • "Draped aorta" sign: Aortic posterior wall not separable from vertebral body
  • Active extravasation of contrast = life-threatening emergency (EVAR or open surgery)

9. Renal and Ureteric Colic

  • Non-contrast CT urogram: Most sensitive for calculi
  • Ureteric calculus: Hyperattenuating focus in ureter with proximal hydronephrosis, perinephric/periureteric fat stranding
  • "Rim sign": Soft tissue rim around calculus

10. Gynecological Emergencies

  • Ovarian torsion: Enlarged ovary, edematous stroma, peripheral follicles, absent enhancement
  • Ruptured ectopic: Adnexal mass, tubal ring, free pelvic blood
  • Fibroids: Well-defined hypodense or calcified uterine masses

Advantages of MDCT over Other Modalities

ModalityLimitationMDCT Advantage
Plain X-rayLow sensitivity, no organ detailAll organs, multiplanar, high sensitivity
UltrasoundOperator-dependent, limited by bowel gas, obesityConsistent, reproducible, not limited by gas
MRISlow, not available 24/7, motion artifactsFast, available, no breath-hold needed
FluoroscopyLimited to GI tractAll structures

Limitations of MDCT

  • Radiation exposure (especially in young patients, pregnancy)
  • Iodinated contrast: Nephrotoxicity, anaphylaxis
  • False negatives in early/subtle disease
  • Requires patient cooperation (motion artifacts)
  • Cost
For pregnancy: MRI preferred; if unavailable, CT may still be performed when benefit exceeds risk.

Q.41 ELASTOGRAPHY IN LIVER LESIONS (30 Marks)

Introduction

Elastography is a non-invasive imaging technique that measures the mechanical properties (stiffness/elasticity) of tissue. It is based on the principle that diseased tissue (fibrosis, cirrhosis, malignant tumor) is stiffer than normal tissue. It has transformed the assessment of liver disease, reducing the need for liver biopsy.

Principle

  • Soft tissue deformation (strain) in response to an applied force is measured
  • Stiff tissue deforms less than soft tissue
  • Liver stiffness is expressed as kPa (kiloPascals) or m/s (velocity of shear wave)
  • Normal liver: 2-6 kPa; Cirrhotic liver: >12-14 kPa

Types of Elastography

A. Ultrasound-Based Elastography

1. Transient Elastography (TE) - FibroScan
  • Most established method
  • A mechanical vibration (50 Hz) creates a shear wave propagating through liver
  • The shear wave velocity is measured by pulse-echo ultrasound
  • Velocity correlates with liver stiffness
  • Probe placed intercostally (right lobe)
  • Result: LSM (Liver Stiffness Measurement) in kPa
  • Limitations: Cannot be performed in ascites, obesity (XL probe available), cannot guide to specific region, no imaging
2. Point Shear Wave Elastography (pSWE) / Acoustic Radiation Force Impulse (ARFI)
  • Focused acoustic pulse displaces tissue → generates shear waves
  • Measures velocity at a specific point of interest
  • Can be combined with real-time B-mode imaging
  • Advantage over TE: Can be performed with ascites, targets specific region
3. 2D Shear Wave Elastography (2D-SWE)
  • Generates color elastogram overlaid on B-mode image
  • Real-time 2D map of liver stiffness
  • Advantage: Targets specific lesions, larger sampling area, real-time visualization
  • Can differentiate focal liver lesions
4. Strain Elastography (Compression Elastography)
  • Manual compression of tissue → measures strain
  • Qualitative (color map) - not quantitative
  • Limited hepatic use; better for superficial lesions (breast, thyroid)

B. MR Elastography (MRE)

  • Mechanical driver applied to liver (60-80 Hz vibrations)
  • Phase-contrast MRI sequences detect wave propagation through liver
  • Generates quantitative stiffness maps (elastograms)
  • Advantages over US-based: Not affected by obesity, ascites, iron overload; images entire liver; higher accuracy
  • Disadvantage: Expensive, less available, longer acquisition time
  • Can accurately assess stiffness of fatty livers (unlike transient elastography which is affected by steatosis)
  • Role in assessing portal hypertension: Spleen stiffness correlates with portal pressure

Liver Fibrosis Staging

The main clinical use of elastography is staging liver fibrosis (Metavir score):
Metavir ScoreDescriptionTE Stiffness (kPa)
F0No fibrosis< 6
F1Mild fibrosis6 - 7.1
F2Moderate fibrosis7.2 - 9.5
F3Severe fibrosis (bridging)9.6 - 12.4
F4Cirrhosis> 12.5

Elastography in Focal Liver Lesions

Benign Lesions

  • Simple cysts: Very soft (low stiffness) - cannot propagate shear wave (no solid components)
  • Hemangioma: Variable; typically soft; may appear blue (soft) on color maps
  • FNH (Focal Nodular Hyperplasia): Slightly stiffer than normal liver but softer than malignancy
  • Hepatic adenoma: Soft to intermediate stiffness

Malignant Lesions

  • Hepatocellular Carcinoma (HCC): Stiff lesion; higher stiffness compared to surrounding cirrhotic liver
  • Metastases: Generally stiff (especially from colorectal, breast cancers)
  • Cholangiocarcinoma: Very stiff (desmoplastic reaction)

Key Role: Characterizing Focal Liver Lesions

  • 2D-SWE and pSWE can target focal lesions:
    • Stiffness > 34.5 kPa: Suggests malignancy
    • Lower stiffness: More likely benign
    • Not yet replacing other modalities but adds functional information

Clinical Applications of Liver Elastography

  1. Staging hepatic fibrosis in chronic liver disease (hepatitis B, C, NAFLD/NASH, alcohol) - replacing liver biopsy in many cases
  2. Monitoring treatment response (antiviral therapy, alcohol abstinence) - decrease in stiffness
  3. Predicting portal hypertension and esophageal varices (spleen stiffness > 54 kPa predicts varices)
  4. Detecting cirrhosis and its complications
  5. Guiding biopsy - sampling from areas of highest stiffness (most severe disease)
  6. Differentiating benign from malignant focal lesions (supplementary role)
  7. Liver transplant assessment - donor evaluation, post-transplant fibrosis

Advantages Over Liver Biopsy

ParameterLiver BiopsyElastography
InvasiveYesNo
ComplicationsBleeding, infection, painNone
Sampling errorHigh (1/50,000 of liver)No (entire lobe assessed)
RepeatabilityLimitedUnlimited
Real-timeNoYes
CostHighModerate

Limitations of Elastography

  • Cannot distinguish cause of fibrosis
  • High stiffness in acute hepatitis (inflammation, not fibrosis)
  • Affected by: Ascites (TE), high BMI, bile duct obstruction (overestimates fibrosis), cardiac congestion
  • Operator-dependent (US methods)
  • Cannot characterize all focal lesions definitively

Q.42 SEGMENTAL ANATOMY OF LIVER BY CT + CECT PHASES + FOCAL LIVER LESIONS (30 Marks)

Part A: Segmental Anatomy of Liver by CT Scan

Couinaud Segmental Anatomy

The liver is divided into 8 functional segments (I-VIII) according to the Couinaud classification, based on hepatic venous drainage and portal venous inflow. Each segment has independent portal pedicle (portal vein, hepatic artery, bile duct) and hepatic venous drainage, allowing anatomical resection.
Anatomical Divisions:
  • Right and Left Liver: Divided by the Middle Hepatic Vein (MHV) and the plane through the gallbladder fossa to IVC (Cantlie's line)
  • Left Liver Lobes: Further divided by the left hepatic vein (LHV) and round ligament (falciform ligament)
  • Right Liver Lobes: Divided by the right hepatic vein (RHV) into anterior and posterior sectors

The 8 Segments

Segment I (Caudate Lobe):
  • Posteriorly between IVC and left portal vein
  • Has dual portal supply and drains directly into IVC via short hepatic veins
  • Seen posterior to hepatoduodenal ligament on CT
Left Liver (Segments I, II, III, IV):
SegmentLocationCT Landmark
ICaudate lobe (posterior)Behind left portal vein, anterior to IVC
IILeft lateral superiorAbove left portal vein, left of LHV
IIILeft lateral inferiorBelow left portal vein, left of round ligament
IVLeft medial (quadrate lobe)Between round ligament and MHV/gallbladder fossa
IVaLeft medial superiorAbove umbilical fissure plane
IVbLeft medial inferiorBelow umbilical fissure plane
Right Liver (Segments V, VI, VII, VIII):
SegmentLocationCT Landmark
VRight anterior inferiorBelow right portal vein, anterior to RHV
VIRight posterior inferiorBelow right portal vein, posterior to RHV
VIIRight posterior superiorAbove right portal vein, posterior to RHV
VIIIRight anterior superiorAbove right portal vein, anterior to RHV

CT Identification Method

Three key CT levels (hepatic vein level → portal vein level → inferior):
Level 1 - Hepatic Vein Level (above porta hepatis):
  • Three hepatic veins (LHV, MHV, RHV) seen draining into IVC
  • Segments II, VII, VIII visible at this level
Level 2 - Portal Vein Bifurcation Level:
  • Right and left portal veins visible
  • All 8 segments partially visible
Level 3 - Gallbladder Fossa / Umbilical Fissure Level:
  • Segments III, IVb, V, VI, I visible

Part B: Enhancement Phases of Liver on CECT

Why Multiphase CT?

The liver has a dual blood supply:
  • Hepatic artery: 25% of blood supply, 50% of oxygen
  • Portal vein: 75% of blood supply, 50% of oxygen
Normal hepatic parenchyma enhances mainly in portal venous phase. Liver tumors (HCC, hypervascular metastases) rely on hepatic artery supply → enhance in arterial phase. This difference enables lesion characterization.

The Four Enhancement Phases

1. Non-Contrast (Plain) Phase (0 sec):
  • Baseline attenuation
  • Detects: Calcification, fat, hemorrhage (hyperattenuating blood), biliary stones
  • Normal liver: 50-70 HU
  • Fat: -20 to -80 HU (suggests steatosis)
  • Hemorrhage: 50-80 HU
2. Late Arterial Phase (25-35 seconds after IV contrast):
  • Hepatic artery and its branches are opacified
  • Portal vein just beginning to opacify
  • Normal liver parenchyma: 70-80 HU (moderately enhanced)
  • Hypervascular lesions light up: HCC, FNH, hepatic adenoma, hemangioma (peripheral nodular enhancement), hypervascular metastases (carcinoid, RCC, thyroid, breast)
  • Celiac, SMA, hepatic artery anatomy assessment
3. Portal Venous Phase (60-70 seconds):
  • Optimal phase for normal liver parenchyma (highest liver enhancement ~120-130 HU)
  • Portal vein fully opacified
  • Liver reaches peak enhancement
  • Hypervascular lesions may "washout" - become iso/hypodense (HCC washout appearance)
  • Hypovascular lesions best seen: Most metastases, cholangiocarcinoma, abscesses
  • Hepatic veins and IVC opacified
4. Delayed / Equilibrium Phase (3-5 minutes):
  • Contrast redistributes to extravascular space
  • Most lesions become isodense to liver (equilibration)
  • Persistent enhancement (enhancement on delayed phase):
    • Hemangiomas: Progressive centripetal fill-in, complete fill-in on delayed
    • Cholangiocarcinoma: Peripheral washout, central/delayed enhancement (fibrous stroma)
    • Fibrotic scars (FNH): Central scar enhances on delayed
  • Hepatobiliary phase (with hepatocyte-specific agents like Gd-EOB-DTPA / Primovist): 20 minutes post-injection; hepatocytes take up agent → HCC and metastases appear dark (no uptake)

Part C: Causes of Focal Liver Lesions

Benign Focal Liver Lesions

LesionCT Appearance
Simple cystWell-defined, water density (0-20 HU), no enhancement, no wall
HemangiomaHypodense on plain; peripheral nodular enhancement in arterial phase; progressive centripetal fill-in; isodense on delayed
FNHIso/hypodense on plain; homogeneous intense arterial enhancement; central stellate scar (hypodense); scar enhances on delayed
Hepatic adenomaWell-defined, often with fat/hemorrhage; heterogeneous arterial enhancement; may have capsule
Hydatid cystDaughter cysts within mother cyst; calcified wall; "water lily sign" (collapsed membrane)
Hepatic abscessRim-enhancing low-density collection; "cluster sign" (multiple small lesions coalescing); perilesional edema

Malignant Focal Liver Lesions

LesionCT Appearance
HCCArterial hyperenhancement + portal venous washout + capsule = LI-RADS 5; mosaic pattern; portal vein tumor thrombus
MetastasesUsually hypodense (most), peripheral ring enhancement; may be hypervascular (RCC, carcinoid, neuroendocrine); target sign
CholangiocarcinomaPeripheral intrahepatic (mass-forming): irregular hypodense mass; delayed central enhancement (fibrous stroma); biliary dilatation
HepatoblastomaChildren; large heterogeneous mass; calcification common
AngiosarcomaHeterogeneous; hemorrhage; rapid filling

Q.43 CROHN'S DISEASE (30 Marks)

Introduction

Crohn's disease is a chronic granulomatous transmural inflammatory disease that can affect any part of the GI tract from mouth to anus, with a predilection for the terminal ileum and ileocecal region (50-60% of cases). It follows a relapsing-remitting course.

Pathological Features (Basis of Radiological Findings)

  • Transmural inflammation (all layers - mucosa to serosa)
  • Skip lesions - alternating diseased and normal segments
  • Granuloma formation (non-caseating)
  • Mucosal ulceration - aphthous ulcers → longitudinal ulcers → cobblestone mucosa → deep fissuring ulcers
  • Fibrosis and strictures (from chronic inflammation)
  • Fistula and sinus tract formation (due to transmural ulceration)
  • Creeping fat (mesenteric fat wrapping around bowel)
  • Lymphoid aggregates - cobblestone appearance

Sites of Involvement

SiteFrequency
Terminal ileum + cecum50%
Small bowel alone30%
Colon alone20%
Esophagus, stomach, duodenum<5%
Perianal disease (fistulae, abscesses)30%

Radiological Investigations

1. Plain X-Ray / AXR

  • Dilated small bowel (in obstruction)
  • Air-fluid levels
  • Fecal loading (colonic disease)
  • Toxic megacolon (rare in Crohn's)
  • Bowel wall thickening (hazy outer margin of bowel)

2. Small Bowel Barium Studies (Enteroclysis / Small Bowel Follow-Through)

Historical gold standard for small bowel
Findings:
  • Aphthous ulcers: Small target lesions - central barium dot surrounded by lucent halo (earliest mucosal change)
  • Cobblestone appearance: Network of longitudinal and transverse ulcers surrounding islands of edematous mucosa
  • String sign of Kantor: Long narrow stricture in terminal ileum (most characteristic) due to fibrosis/spasm; normal mucosa cannot be seen
  • Skip lesions: Normal bowel between diseased segments
  • Terminal ileal thickening and narrowing
  • Fistulae: Sinus tracts between bowel loops, between bowel and bladder (colovesical fistula), bowel and skin (enterocutaneous)
  • Widened ileocecal junction
  • Rose-thorn ulcers: Deep penetrating ulcers into thickened wall
  • Thumbprinting: Submucosal edema in acute colonic disease

3. CT Enterography (CTE) - Current Gold Standard

Neutral oral contrast + IV contrast; prone positioning
CT findings:
  • Mural thickening (>3-4 mm; normal <3 mm)
  • Mural stratification - "target sign" / "double halo sign":
    • Inner ring: Hyperenhancing mucosa
    • Middle ring: Submucosal edema (fat density)
    • Outer ring: Muscularis
  • Mucosal hyperenhancement: Active inflammation (increased vascularity)
  • Mesenteric fat stranding: Perilesional inflammation
  • "Comb sign": Engorgement of vasa recta (mesenteric vessels) perpendicular to bowel wall - indicates active inflammation
  • Creeping fat: Mesenteric fat proliferating around bowel
  • Strictures: Wall thickening + luminal narrowing
  • Fistulae: Tracts connecting bowel loops or to other structures
  • Abscesses: Rim-enhancing collections
  • Lymphadenopathy: Mesenteric nodes
  • Skip lesions: Diseased segments with normal intervening bowel

4. MR Enterography (MRE)

Preferred in younger patients (no radiation) and for assessing disease activity
  • Equal sensitivity and specificity to CTE for small bowel Crohn's
  • Better for:
    • Perianal fistulae (MRI is gold standard)
    • Assessing disease activity (T1 post-contrast enhancement, T2 mural edema)
    • Repeated follow-up (no radiation)
  • MRI activity score: MaRIA (Magnetic Resonance Index of Activity)
  • Wall thickening, mural hyperenhancement, perimural edema, ulcers on MRE
Sequences:
  • SSFSE/HASTE (T2): Bowel wall edema, fluid collections
  • T1 + contrast: Mucosal enhancement, fistulae
  • DWI: Restricted diffusion in active inflammation

5. Ultrasound

  • Bowel wall thickening >3 mm
  • Loss of normal bowel wall stratification
  • Increased Doppler flow (active disease)
  • Mesenteric fat echogenicity
  • Abscesses, fistulae
  • Limited by gas and obesity

6. Capsule Endoscopy

  • Most sensitive for mucosal disease (aphthous ulcers, subtle changes)
  • Cannot be used in strictures (risk of retention)
  • Used in suspected small bowel Crohn's with negative cross-sectional imaging

7. Nuclear Medicine

  • 99mTc-HMPAO leukocyte scintigraphy / 18F-FDG PET:
    • Assess extent and activity of disease
    • Useful when contrast is contraindicated

Complications and Their Radiological Findings

ComplicationRadiology
Stricture / ObstructionDilated proximal bowel, transition point on CT
FistulaTract between structures on CT/MRI/fluoroscopy
AbscessRim-enhancing collection on CT
PerforationFree air on AXR/CT
Toxic megacolonColonic dilation >6 cm on AXR
Carcinoma (small bowel adenocarcinoma)Mass in Crohn's segment, worse prognosis
Perianal diseaseMRI: fistula classification (Parks/St. James's)

Differentiating Crohn's from Ulcerative Colitis

FeatureCrohn'sUC
DistributionAny GI tractRectum → colon only
RectumOften sparedAlways involved
InflammationTransmuralMucosal only
Skip lesionsYesNo (continuous)
StricturesCommonRare
FistulaeCommonAbsent
GranulomasYesNo
Terminal ileumInvolved (backwash ileitis in UC)Usually spared
CobblestoneYesNo

Q.44 EXPLAINING EACH PHASE (CECT Liver Enhancement Phases - Detailed) (30 Marks)

(This question appears to continue from Q.42 - it specifically asks about explaining each CECT phase in detail. Full detailed answer below.)

Introduction to CECT Liver Phases

Contrast-Enhanced CT (CECT) of the liver uses intravenous iodinated contrast to characterize liver lesions and pathology. The dual blood supply of the liver creates distinct temporal phases of enhancement. Understanding each phase is essential for lesion characterization.

Pharmacokinetics of Iodinated Contrast

  • Administered IV (100-120 ml at 3-4 ml/sec)
  • Distributes first in intravascular space, then extravascular extracellular space
  • Not taken up by hepatocytes (unlike MRI hepatobiliary agents)
  • Excreted by glomerular filtration
  • Peak liver enhancement depends on timing of acquisition

Phase 1: Non-Contrast (Plain) CT

Timing: Before contrast injection
What it shows:
  • Baseline liver attenuation: Normal 50-70 HU (higher than spleen)
  • Steatosis: Liver attenuation < 48 HU or liver-spleen ratio < 0.9 (fatty infiltration appears dark)
  • Hemosiderosis/Iron overload: Very high attenuation liver (>75 HU)
  • Calcification: Gallstones, calcified granulomas, old hemangioma, parasitic cysts (Echinococcus)
  • Hemorrhage: Hyperattenuating fresh blood (50-80 HU) in HCC, hepatic adenoma rupture
  • Biliary stones
  • Gas: Pneumobilia, hepatic abscess gas
Lesion attenuation on plain:
  • Cysts: 0-20 HU (very dark - water density)
  • Hemangiomas: 35-45 HU (slightly hypodense)
  • HCC: Variable, may contain fat (10-15 HU areas), calcification rare

Phase 2: Arterial Phase

Timing: 25-35 seconds post-injection (scan triggered when aorta reaches threshold ~100-150 HU using bolus tracking / SmartPrep)
What enhances:
  • Hepatic artery and its branches: Brilliant enhancement (300-400 HU)
  • Abdominal aorta: Peak enhancement
  • Early portal vein: Beginning to opacify (~50-70 HU)
  • Liver parenchyma: Mild enhancement (70-90 HU) from arterial supply
Why divided into early and late arterial:
  • Early arterial: Only artery opacified (portal not yet visible) - best for vascular anatomy
  • Late arterial (hepatic arterial dominant phase): Hepatic artery branches opacified, portal vein just becoming visible - BEST PHASE for hypervascular liver tumors
Hypervascular lesions (enhance in arterial phase - bright relative to liver):
  • HCC: Bright arterial enhancement (fed by abnormal hepatic arteries - neovascularity)
  • FNH: Intense homogeneous enhancement (central scar remains dark)
  • Hepatic adenoma: Peripheral arterial enhancement, heterogeneous (may contain hemorrhage/fat)
  • Hemangioma: Peripheral nodular enhancement (globular pattern matching aorta/IVC)
  • Hypervascular metastases: RCC, carcinoid, neuroendocrine tumor, thyroid, melanoma, choriocarcinoma
  • HCC in cirrhosis: Classic arterial hyperenhancement is hallmark
Pathological conditions seen on arterial phase:
  • Hepatic artery aneurysm / pseudoaneurysm
  • Arteriovenous fistulae (hepatic artery to portal vein - triangular or wedge-shaped enhancement near capsule)
  • Active arterial hemorrhage (contrast extravasation)
  • Hepatic trauma (laceration, contusion, active bleed)

Phase 3: Portal Venous Phase

Timing: 60-80 seconds post-injection
What enhances:
  • Liver parenchyma reaches peak enhancement (~120-140 HU) - due to portal venous inflow (75% of blood supply)
  • Portal vein: Fully opacified (90-120 HU)
  • Hepatic veins: Beginning to opacify
  • Spleen: Complete and uniform enhancement (no more "tiger" stripe artifact)
  • Bowel wall: Good mucosal and mural enhancement
  • Kidneys: Nephrographic phase
This is the STANDARD phase for:
  • Overall liver parenchyma assessment
  • Detection of hypovascular lesions (appear dark against bright liver):
    • Most metastases (colorectal, pancreatic, gastric, lung)
    • Cholangiocarcinoma
    • Liver abscesses
    • Biliary cystadenocarcinoma
  • Portal vein: Thrombosis, tumor thrombus (enhancing = tumor; non-enhancing = bland thrombus)
  • Splenomegaly, splenic lesions
  • Bowel wall pathology (ischemia, inflammation)
  • IVC patency
Washout phenomenon (key for HCC diagnosis):
  • HCC that was bright in arterial phase becomes relatively hypodense in portal venous phase = "washout"
  • Arterial hyperenhancement + portal venous washout = LI-RADS 4/5 for HCC
Perilesional enhancement: May be seen around metastases, abscesses due to surrounding reactive changes

Phase 4: Delayed / Equilibrium Phase

Timing: 3-5 minutes post-injection (sometimes 10-15 minutes for specific indications)
What enhances:
  • Contrast equilibrates between intravascular and extravascular extracellular spaces
  • Liver attenuation falls back towards baseline
  • Most lesions become isodense (no longer visible)
  • Only specific lesions retain contrast
Lesions with characteristic delayed enhancement:
1. Hemangioma:
  • Progressive centripetal fill-in from arterial phase
  • Complete or near-complete fill-in on delayed phase
  • Remains isodense to blood pool (compare with aorta/IVC density)
  • Key: Isodense to aorta on all phases (blood pool lesion)
2. Cholangiocarcinoma (intrahepatic mass-forming):
  • "Progressive delayed enhancement" / "central fill-in"
  • Due to desmoplastic fibrous stroma - contrast enters fibrous tissue slowly
  • Becomes MORE DENSE on delayed phase (unlike HCC)
  • Peripheral washout, central progressive enhancement
3. FNH (Focal Nodular Hyperplasia):
  • Central stellate scar: Hypodense on plain and arterial; enhances on delayed (scar contains myxomatous stroma and vessels)
  • Lesion itself becomes isodense on delayed (rapid washout)
4. Hepatic Fibrosis:
  • Areas of fibrosis retain contrast on delayed (progressive fibrotic enhancement)
5. Hepatoblastoma / Some metastases:
  • Fibrous components may show delayed enhancement

Phase 5: Hepatobiliary Phase (MRI specific - Gd-EOB-DTPA / Primovist)

Timing: 20 minutes post-injection (MRI only)
  • Hepatocyte-specific contrast agent taken up by normal hepatocytes via OATP1B1/B3 transporters and excreted into bile
  • Normal liver and FNH: Bright (uptake)
  • HCC, metastases, adenoma (except in rare cases): Dark (no uptake)
  • Bile ducts: Visualized (biliary anatomy)
  • Focal biliary strictures, leaks visible

Summary Table: Lesion Enhancement Pattern

LesionPlainArterialPortal VenousDelayed
CystDarkNoneNoneNone
HemangiomaSlightly darkPeripheral nodularProgressive fillComplete fill-in = aorta
FNHIso/hypoIntense homoIsodenseScar enhances
AdenomaHypo ± fat/bloodPeripheral enhancementWashoutCapsule may enhance
HCCVariableBrightWashoutWashout + capsule
Metastases (hypo)DarkRim ± hypoDarkDark/rim
Metastases (hyper)DarkBrightWashoutDark
CholangiocarcinomaDarkPeripheralPeripheral washoutCentral fill
AbscessDarkRimRimRim

Q.45 CAUSES OF ACUTE ABDOMEN IN ADULT + FIVE COMMON CONDITIONS WITH RADIOLOGICAL FINDINGS (30 Marks)

Definition

Acute abdomen is a clinical syndrome of sudden onset severe abdominal pain, often requiring urgent surgical or medical intervention, caused by intraperitoneal, retroperitoneal, or extra-abdominal disease.

Classification of Causes

I. Inflammatory / Infective
  1. Acute appendicitis
  2. Acute cholecystitis / acute cholangitis
  3. Acute pancreatitis
  4. Diverticulitis
  5. Peritonitis (primary / secondary)
  6. Pelvic inflammatory disease
  7. Liver/splenic abscess
  8. Meckel's diverticulitis
II. Obstructive
  1. Small bowel obstruction (adhesions, hernia, volvulus, intussusception)
  2. Large bowel obstruction (carcinoma, volvulus, fecal impaction)
  3. Biliary colic / choledocholithiasis
  4. Renal/ureteric colic
III. Perforation
  1. Perforated peptic ulcer
  2. Perforated appendix
  3. Perforated diverticulum
  4. Perforated carcinoma
  5. Boerhaave syndrome (esophageal rupture)
IV. Ischemia / Vascular
  1. Acute mesenteric ischemia
  2. Ruptured AAA
  3. Ischemic colitis
  4. Splenic infarction
  5. Ovarian / testicular torsion
V. Hemorrhagic
  1. Ruptured ectopic pregnancy
  2. Ruptured ovarian cyst (hemorrhagic)
  3. Spontaneous hepatic / splenic rupture
  4. Anticoagulant-related hemorrhage (rectus sheath hematoma)
VI. Gynecological
  1. Ectopic pregnancy (ruptured / unruptured)
  2. Ovarian torsion
  3. Severe endometriosis
VII. Urological
  1. Acute urinary retention
  2. Perinephric abscess
  3. Renal vein thrombosis
VIII. Extra-Abdominal (Referred Pain)
  1. Acute myocardial infarction (inferior MI)
  2. Lower lobe pneumonia / empyema
  3. Diabetic ketoacidosis
  4. Sickle cell crisis
  5. Herpes zoster

Five Common Conditions with Radiological Findings

1. ACUTE APPENDICITIS

Clinical Features: RIF pain, Rovsing's sign, peritonism, fever, leukocytosis
Plain AXR:
  • Usually normal
  • Fecalith (calcified appendicolith) in RIF in 15% (strongly suggestive)
  • Localized ileus / sentinel loop
  • Obliteration of psoas margin
  • Soft tissue mass if abscess
Ultrasound (First line in children/young females):
  • Noncompressible blind-ending tubular structure >6 mm diameter (outer-to-outer)
  • Target sign in cross-section (concentric rings)
  • Appendicolith: Echogenic focus with acoustic shadow
  • Periappendiceal fat echogenicity (inflammation)
  • Free fluid in RIF
  • Absent peristalsis in appendix
  • Power Doppler: Hyperemia (active inflammation)
  • Perforation: Loss of wall integrity, loculated fluid
CT (Best single modality - sensitivity 95%, specificity 97%):
  • Appendix > 6 mm in diameter with mural thickening
  • Appendicolith (90% if seen = appendicitis)
  • Periappendiceal fat stranding (haziness)
  • Periappendiceal free fluid
  • Appendiceal wall enhancement
  • Loss of appendiceal wall integrity = perforation
  • Abscess: Rim-enhancing collection in RIF/pelvis
  • Phlegmon: Inflammatory soft tissue mass
MRI (Pregnancy):
  • T2: Edematous dilated appendix with periappendiceal T2 signal

2. ACUTE CHOLECYSTITIS

Clinical Features: RUQ colicky pain, Murphy's sign, fever, leukocytosis
Ultrasound (Investigation of choice):
  • Gallstones (echogenic with posterior acoustic shadow)
  • Distended GB (length >9 cm, width >4 cm)
  • Mural thickening (>3 mm) - especially anteriorly
  • Pericholecystic fluid
  • Murphy's sign on US (maximum tenderness when probe over GB)
  • Subserosal edema ("halo sign")
  • Gangrenous cholecystitis: Intraluminal membrane, irregular thickened wall, absent peristalsis of mobile stones
  • Emphysematous cholecystitis: Echogenic foci in GB wall with ring-down artifact (gas)
CT:
  • Distended GB with mural thickening
  • Pericholecystic fat stranding
  • Gallstones (calcified)
  • Hyperenhancing inflamed GB wall
  • Complications: Gangrenous change (absent enhancement), empyema (milk of calcium bile), perforation (discontinuous wall, pericholecystic abscess), cholecystoenteric fistula
HIDA Scan (Hepatobiliary Iminodiacetic Acid Scintigraphy):
  • Technetium-99m HIDA injected IV - taken up by hepatocytes, excreted into bile
  • Positive scan: GB NOT visualized by 60-90 minutes (cystic duct obstruction)
  • 99% sensitivity for acute cholecystitis
MRCP:
  • Choledocholithiasis (stones as dark filling defects in bright bile duct)
  • Biliary anatomy

3. ACUTE PANCREATITIS

Clinical Features: Severe epigastric pain radiating to back, N&V, hyperamylasemia
Plain AXR:
  • "Sentinel loop" (dilated proximal jejunum/duodenum due to local ileus)
  • "Colon cutoff sign" (gas stops at splenic flexure due to transverse mesocolon inflammation)
  • Loss of psoas shadow
  • Pancreatic calcification (chronic pancreatitis)
Ultrasound (First-line - limited by gas):
  • Edematous/hypoechoic pancreas
  • Peripancreatic fluid
  • Gallstones (identify biliary cause)
  • CBD dilatation
  • Limited by overlying bowel gas
CT (CECT) - CT Severity Index (Balthazar Score): Best performed at 48-72 hours for staging necrosis
CT GradeDescriptionPoints
ANormal pancreas0
BPancreatic enlargement1
CPancreatic + peripancreatic inflammation2
DOne fluid collection3
ETwo or more fluid collections / retroperitoneal gas4
NecrosisCT FindingPoints
NoneNormal enhancement0
< 30%Small area non-enhancement2
30-50%Moderate non-enhancement4
> 50%Majority non-enhancement6
Total CT Severity Index = Grade score + Necrosis score (max 10)
  • 0-3: Mild (low morbidity/mortality)
  • 4-6: Moderate
  • 7-10: Severe (morbidity >17%, mortality up to 17%)
CT Findings:
  • Pancreatic edema, enlargement
  • Peripancreatic fat stranding
  • Necrosis: Non-enhancing parenchyma (black areas on CECT) - >30% = severe
  • Fluid collections: Acute peripancreatic fluid collection (APFC) - no defined wall; becomes pseudocyst after 4 weeks (defined wall)
  • Walled-off necrosis (WON): After 4 weeks, encapsulated necrotic collection
  • Complications: Splenic vein thrombosis, hepatic artery pseudoaneurysm, biliary obstruction
MRI / MRCP:
  • Better for: Stone detection, ductal communication with fluid collection, no radiation
  • MRCP: Pancreatic duct disruption / leakage
  • Superior for characterizing fluid collections (debris vs pure fluid)

4. SMALL BOWEL OBSTRUCTION (SBO)

Clinical Features: Colicky pain, vomiting, distension, constipation
Common Causes: Post-operative adhesions (60%), hernia (20%), tumor, volvulus, intussusception, Crohn's stricture
Plain AXR (First-line):
  • Multiple dilated small bowel loops (>2.5-3 cm) with air-fluid levels (Stepladder pattern)
  • Central distribution (jejunum) vs peripheral (ileum)
  • Valvulae conniventes (folds across entire bowel width) = small bowel
  • Haustral folds (partial width) = large bowel
  • Absent or minimal gas in colon (if complete obstruction)
  • String of beads sign: Tiny air bubbles trapped between valvulae conniventes (seen in complete SBO with fluid-filled loops)
Erect AXR:
  • Air-fluid levels at different heights in same loop = small bowel
  • Air-fluid levels at same height = large bowel
CT (Best investigation):
  • Transition point: Abrupt change from dilated to collapsed bowel (key finding)
  • Cause at transition: Adhesions (no mass), hernia (loops through defect), tumor (mass), volvulus (whirl sign)
  • Closed loop obstruction: C/U-shaped loop with two transition points, radial mesenteric vessels, high risk of strangulation
  • Strangulation signs: Mural thickening, abnormal wall enhancement, pneumatosis, portal venous gas, mesenteric haziness, ascites, hyperattenuating bowel wall (hemorrhage)
  • "Whirl sign": Twisted mesentery in volvulus
  • "Beak sign": Tapered bowel at transition
MRI Enterography:
  • Used in younger patients
  • Useful for Crohn's stricture, radiation enteropathy

5. RUPTURED ABDOMINAL AORTIC ANEURYSM (AAA)

Definition: Aortic diameter > 3 cm; >5.5 cm = high rupture risk
Clinical Features: Sudden severe abdominal/back pain, pulsatile abdominal mass, hypotension, collapse - classical triad (often incomplete)
Ultrasound:
  • Rapid bedside assessment (FAST/EFAST)
  • Aortic diameter >3 cm = aneurysm
  • Thrombus lining the aneurysm sac
  • Cannot reliably detect retroperitoneal rupture
  • Free intraperitoneal blood (anechoic fluid)
CT (Gold Standard - MUST be fast):
  • Non-contrast CT: Aortic diameter measurement (outer wall to outer wall); retroperitoneal hematoma (hyperdense blood); aortic wall calcification
  • CECT (Arterial phase):
    • Active contrast extravasation = active rupture
    • "Draped aorta" sign: Posterior aortic wall not separated from vertebral body (posterior rupture/periadventitial hematoma)
    • Hyperattenuating periaortic hematoma
    • Extent: Suprarenal or infrarenal (surgically important)
    • Iliac arteries: Extension of aneurysm
  • CECT findings:
    • Intraluminal thrombus (low attenuation lining)
    • Luminal flow channel (enhancing)
    • Periaortic inflammatory changes (inflammatory AAA)
    • IVC compression (large AAA)
    • Aortoenteric fistula (erosion into duodenum - rare)
CTA Planning:
  • For EVAR (endovascular aortic repair): Measure neck length, iliac anatomy, access vessel diameter
  • 3D reconstruction for stent graft sizing
MRI / MRA:
  • Non-urgent cases; chronic aneurysm follow-up
  • Better soft tissue characterization of inflammatory AAA
  • No radiation

Q.46 LIVER MRI SEQUENCES (30 Marks)

Introduction

MRI is the most versatile imaging modality for liver assessment. It offers superior soft tissue contrast, no ionizing radiation, and with hepatocyte-specific contrast agents, provides both morphological and functional information. A comprehensive liver MRI protocol combines multiple sequences to detect and characterize focal lesions, assess diffuse disease, and evaluate biliary anatomy.

Basic Principles

  • T1-weighted imaging: Signal proportional to T1 relaxation; fat, blood (subacute), proteinaceous material appear bright; fluid appears dark
  • T2-weighted imaging: Signal proportional to T2 relaxation; fluid (cysts, bile) appears bright; fibrous tissue appears dark
  • Gradient Echo (GRE): Fast acquisition, used for dynamic contrast; susceptible to field inhomogeneity (susceptibility effect)
  • Echo Planar Imaging (EPI): Very fast, used for DWI
  • Parallel imaging (SENSE/GRAPPA): Reduces acquisition time

Complete Liver MRI Protocol - Sequences

1. T2-Weighted Sequences

a. T2 HASTE/SSFSE (Half Fourier Acquired Single Shot Turbo Spin Echo):
  • Breath-hold single shot; fast
  • Fluid: Bright; Solid lesions: Variable
  • Best for: Cysts (very bright T2), hemangiomas (moderately bright T2 "light bulb" sign)
  • Detects: Bile duct dilatation, ascites, pleural effusion
b. T2 TSE/FSE (Turbo/Fast Spin Echo) with Fat Saturation:
  • More detailed; multiple breath-holds or respiratory gating
  • Better for lesion characterization
  • Fibrotic lesions (cholangiocarcinoma, scarring): Dark on T2 (short T2)
  • Hemangioma: Very bright (follows fluid)
  • HCC: Moderately bright T2 (higher T2 than surrounding liver)
  • Metastases: Variable T2 (bright if mucinous, hemorrhagic)
c. 3D T2 MRCP (Magnetic Resonance Cholangiopancreatography):
  • Heavily T2-weighted (TR/TE very long)
  • Only fluid remains bright → bile ducts visualized
  • Biliary anatomy: Primary and intrahepatic ducts
  • Choledocholithiasis: Dark stones (filling defects) in bright bile
  • Primary sclerosing cholangitis (PSC): Beading, strictures
  • Biliary strictures, cholangiocarcinoma
  • Pancreatic duct assessment

2. T1-Weighted Sequences

a. T1 GRE In-Phase and Out-of-Phase (Dixon technique):
  • Exploits chemical shift between water and fat protons
  • In-phase (TE ~4.8 ms at 1.5T / ~2.4 ms at 3T): Water + fat signals add
  • Out-of-phase (TE ~2.4 ms at 1.5T / ~1.2 ms at 3T): Water - fat signals cancel
Diagnostic value:
  • Hepatic steatosis: Liver signal drops on out-of-phase (India ink artifact at organ interface)
  • India ink / etching artifact: Black rim around liver (fat-water interface)
  • Drop in SI on out-of-phase compared to in-phase = fat content (diffuse or focal steatosis)
  • HCC: May contain fat (drop in signal) - supports HCC diagnosis
  • Hepatic adenoma: Often contains fat
b. T1 3D GRE (e.g., VIBE, LAVA, THRIVE):
  • Volumetric interpolated breath-hold examination
  • Isotropic voxels; MPR capability
  • Used for dynamic contrast-enhanced series (pre-contrast + multiphase post-contrast)
  • Fat-saturated version: Suppresses fat background, improves lesion-to-liver contrast

3. Dynamic Contrast-Enhanced MRI (DCE-MRI)

The most important component for focal lesion characterization. Uses T1 GRE 3D sequence.
Phases (same as CT, MRI-specific timing):
Pre-contrast T1:
  • Baseline; identifies intrinsic T1 bright lesions (fat, blood, protein)
  • HCC: May have T1 bright foci (fat, copper, glycogen)
  • Hemangioma: T1 dark (fluid)
  • Adenoma: T1 bright (fat, blood)
Arterial Phase (20-25 seconds):
  • Gadolinium-based contrast agent (GBCA): Standard extracellular agents (Gd-DTPA, Gd-DOTA, Gadobutrol) OR hepatocyte-specific agents (Gd-EOB-DTPA/Primovist, Gd-BOPTA/Multihance)
  • Hypervascular lesions bright: HCC, FNH, adenoma, hemangioma (peripheral nodular)
Portal Venous Phase (60-70 seconds):
  • Liver parenchyma peak enhancement
  • Hypovascular lesions visible: Metastases, cholangiocarcinoma
Transitional / Late Phase (3-5 minutes):
  • Hemangioma: Complete fill-in
  • FNH: Central scar enhances
  • Cholangiocarcinoma: Progressive enhancement
  • HCC: Washout appearance (hypointense)

4. Hepatobiliary Phase (HBP) - Unique to MRI

Timing: 15-20 minutes post-injection of hepatocyte-specific GBCA
Agents:
  • Gd-EOB-DTPA (Primovist/Eovist): 50% hepatic excretion; stronger HBP signal
  • Gd-BOPTA (MultiHance): 3-5% hepatic excretion; weaker HBP
Mechanism: OATP1B1/1B3 transporters on hepatocytes take up contrast → bile excretion
Findings:
  • Normal liver / FNH: Bright (uptake) - FNH contains functional hepatocytes
  • HCC: Usually dark (poorly differentiated - OATP downregulated); well-differentiated HCC may show uptake
  • Hepatic adenoma: Dark (no uptake) - exception: HNF1a-mutated adenoma sometimes shows faint uptake
  • Metastases: Dark (no hepatocytes)
  • Cysts, hemangiomas: Dark (no hepatocytes)
  • Bile ducts: Bright (contrast excreted into bile) → dynamic cholangiography possible
  • Biliary anatomy: Leak, fistula, stricture
Clinical value:
  • Detects additional HCC nodules invisible on other phases
  • Differentiates FNH from adenoma (FNH = bright; adenoma = dark on HBP)
  • Biliary mapping pre-surgery

5. Diffusion-Weighted Imaging (DWI)

Principle:
  • Measures Brownian motion (random movement) of water molecules in tissue
  • Restricted diffusion = tightly packed cells (malignancy, abscess) = bright on high b-value DWI
  • Free diffusion = cysts, necrosis = dark on high b-value DWI
Technical parameters:
  • b-values: 0, 50, 400, 800 s/mm² (higher b = more diffusion weighting)
  • ADC map (Apparent Diffusion Coefficient): Calculated from multiple b-values
    • Low ADC = restricted diffusion = malignancy
    • High ADC = free diffusion = cyst, hemangioma
Liver DWI findings:
LesionDWI (b800)ADC
CystDarkVery high (>2.0 × 10⁻³ mm²/s)
HemangiomaDark (low b) → dark/isointense (high b)High
HCCBrightLow
MetastasisBrightLow
AbscessBright (central) with rimLow (pus restricted)
FNHMildly bright or isointenseIntermediate
Normal liverIntermediate signal1.0-1.6 × 10⁻³ mm²/s
Clinical role of DWI:
  • Detection of focal liver lesions (especially metastases) - comparable to CECT for liver mets
  • Characterization: Benign vs malignant
  • Fibrosis assessment (liver stiffness correlates with lower ADC)
  • Treatment response monitoring (successful ablation → ADC increases)
  • Hepatocellular carcinoma - detection and staging

6. Susceptibility Weighted Imaging (SWI) / GRE T2*

  • Detects paramagnetic substances: Iron, calcium, blood, air
  • Iron overload (hemosiderosis, hemochromatosis): Liver very dark (T2* signal loss) - quantitative MRI for iron
  • Hemangiosarcoma: Hemorrhagic areas dark
  • Calcification in echinococcal cyst wall
  • Pneumobilia: Air appears dark

7. Magnetic Resonance Elastography (MRE)

  • Mechanical driver applies external vibrations (60 Hz)
  • Phase-contrast MRI sequence captures wave propagation
  • Generates stiffness maps (elastograms) of entire liver
  • Values:
    • Normal: 2-3 kPa
    • F2 fibrosis: ~3.5 kPa
    • Cirrhosis: >5 kPa
  • More accurate than US elastography; not affected by ascites or obesity
  • Can assess steatotic livers accurately

8. Fat Quantification Sequences (MRI-PDFF)

  • Proton Density Fat Fraction (PDFF): Most accurate non-invasive fat quantification
  • Multi-echo Dixon method: Separates fat and water signals
  • PDFF > 5.5% = hepatic steatosis
  • Grades: S1 (5-17%), S2 (17-33%), S3 (>33%)
  • Important in NAFLD/NASH management

9. MR Angiography (MRA)

  • Phase-contrast MRA or CE-MRA (gadolinium)
  • Hepatic arterial anatomy (pre-TACE, transplant planning)
  • Portal vein patency, Budd-Chiari (hepatic vein thrombosis)
  • IVC involvement

Standard Liver MRI Protocol Summary

SequencePlanePurpose
T2 HASTEAxial + CoronalSurvey, lesion detection
T2 FSE fat-satAxialLesion characterization
T2 MRCPCoronalBiliary anatomy
T1 In/Out-phaseAxialFat detection
T1 3D GRE pre-contrastAxialBaseline T1
T1 3D GRE arterialAxialHypervascular lesions
T1 3D GRE portal venousAxialHypovascular lesions, parenchyma
T1 3D GRE delayedAxialHemangioma, cholangiocarcinoma
Hepatobiliary phase (if Primovist)AxialHCC, FNH vs adenoma, biliary
DWI (b50, 400, 800) + ADCAxialLesion detection and characterization
MRE (if available)AxialFibrosis staging

LI-RADS Classification (Liver Imaging Reporting and Data System)

Used for reporting liver findings on CT/MRI in cirrhotic/at-risk patients:
  • LR-1: Definitely benign
  • LR-2: Probably benign
  • LR-3: Intermediate probability for HCC
  • LR-4: Probably HCC
  • LR-5: Definitely HCC (arterial hyperenhancement + washout on portal/delayed + capsule)
  • LR-M: Probably/definitely malignant, not HCC specific
  • LR-TR: Treated lesion
---All 11 questions are fully answered above. Here is a quick summary of what each answer covers:

What Was Covered - Summary

Q#TopicKey Areas Covered
36Pneumatosis IntestinalisDefinition, classification (primary/secondary), 3 pathogenesis theories, causes, AXR/US/CT findings, benign vs ominous differentiation, portal venous gas vs pneumobilia table
37Meckel's DiverticulumRule of 2s, anatomy, ectopic mucosa, clinical presentations, full imaging (AXR, barium, US, 99mTc Meckel's scan with pharmacological enhancement, CT, MRI, angiography, capsule endoscopy), complications table, treatment
38Acute Abdomen - 50yr FemaleSpecial female considerations, 8-category cause classification (GI/gynae/uro/vascular/hepatic), step-by-step radiology (AXR, US, CECT, MRI, fluoroscopy, nuclear, angiography), full CT findings table, algorithm
39Haemoptysis InvestigationDefinition, causes (with high priority for 40yr male), full imaging (CXR, HRCT, CTPA, CECT, bronchoscopy, bronchial artery angiography with technique, MRI, V/Q scan, PET-CT), algorithm, HRCT vs bronchoscopy comparison
40MDCT - Acute AbdomenTechnical advantages, full CT protocol (4 phases), detailed findings for 10 conditions (perforation, obstruction, appendicitis, cholecystitis, pancreatitis, mesenteric ischemia, diverticulitis, AAA, ureteric colic, gynae), advantages/limitations table
41Elastography - LiverPrinciple, types (TE/FibroScan, pSWE/ARFI, 2D-SWE, strain, MRE), liver fibrosis staging (Metavir + kPa values), focal lesion characterization, clinical applications, vs biopsy comparison, limitations
42Liver CT Segmental Anatomy + CECT Phases + Focal LesionsCouinaud 8-segment system (all segments with CT landmarks, 3-level identification method) + all 4 CECT phases (plain, arterial, portal venous, delayed) + full benign/malignant lesion table
43Crohn's DiseasePathology, skip lesions, site distribution, full imaging (AXR, barium with String sign/cobblestone/aphthous ulcers, CTE with comb sign/target sign, MRE, US, capsule), complications, Crohn's vs UC table
44CECT Phases - DetailedEach of 5 phases explained in depth (plain, early/late arterial, portal venous, delayed, hepatobiliary), pharmacokinetics, washout phenomenon, complete lesion enhancement pattern summary table
45Acute Abdomen - Causes + 5 ConditionsFull cause classification (8 categories), 5 detailed conditions: Appendicitis (US + CT), Cholecystitis (US + CT + HIDA), Pancreatitis (AXR + CT Balthazar score table), Small Bowel Obstruction (AXR + CT), Ruptured AAA (US + CTA + EVAR planning)
46Liver MRI SequencesT2 (HASTE/TSE/MRCP), T1 (in/out-phase Dixon, 3D GRE), dynamic contrast (all phases), hepatobiliary phase (Primovist mechanism), DWI with ADC table, SWI, MRE, PDFF fat quantification, MRA, full protocol summary table, LI-RADS classification
This is a shared conversation. Sign in to Orris to start your own chat.